Case 3: Introduction
In this video, Deborah Toppmeyer, MD, director of the Stacy Goldstein Breast Center and professor of medicine at Robert Wood Johnson Medical School, Rutgers Cancer Institute of New Jersey, introduces the case: Management of Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer.
Editor’s note: The following is an automatically generated transcript of the above video.
"I'm Dr. Deborah Toppmeyer. I'm the Director of the Stacy Goldstein Breast Center and Professor of Medicine at Robert Wood Johnson Medical School at Rutgers Cancer Institute of New Jersey. I want to thank Healio for providing me the opportunity to speak to you today on the management of locally advanced or metastatic hormone receptor-positive breast cancer. My only financial disclosure is my spouse is employed by Merck Pharmaceuticals. So let me just provide a brief outline of our discussion today. First, to discuss treatment options for de-novo or recurrent hormone positive metastatic breast cancer. Second, to optimize selection of first-line treatment in this patient population, and what are treatment options at the time of progression."
Click Here to Manage Email Alerts